1
Issa, D. E., Seefat, R. L., Visser, O., Zweegman, S., Lugtenburg, P. J., Dinmohamed, A. G., Chamuleau, M. E.D.
Veröffentlicht in: Issa , D E , Seefat , R L , Visser , O , Zweegman , S , Lugtenburg , P J , Dinmohamed , A G & Chamuleau , M E D 2021 , ' Primary therapy and survival in patients with Burkitt lymphoma in The Netherlands : a population-based study, 1989-2018 ' , Blood , vol. 137 , no. 20 , pp. 2848-2851 . https://doi.org/10.1182/blood.2020009552;
2021
Veröffentlicht in: Issa , D E , Seefat , R L , Visser , O , Zweegman , S , Lugtenburg , P J , Dinmohamed , A G & Chamuleau , M E D 2021 , ' Primary therapy and survival in patients with Burkitt lymphoma in The Netherlands : a population-based study, 1989-2018 ' , Blood , vol. 137 , no. 20 , pp. 2848-2851 . https://doi.org/10.1182/blood.2020009552;
2021
2
3
4
5
6
7
Aleman, B.M., Nijdam, A., van 't Veer, M.B., Janus, C.P., de Weijer, R.J., Petersen, E.J., Roesink, J., Zijlstra, J.M., Lugtenburg, P.J., van der Maazen, R.W., Raemaekers, J.M., van Leeuwen, F.E.
Veröffentlicht in: Hematological Oncology ; volume 35, issue S2, page 309-309 ; ISSN 0278-0232 1099-1069;
2017
Veröffentlicht in: Hematological Oncology ; volume 35, issue S2, page 309-309 ; ISSN 0278-0232 1099-1069;
2017
8
9
10